Johnson Matthew W, Herrmann Evan S, Sweeney Mary M, LeComte Robert S, Johnson Patrick S
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, 5510 Nathan Shock Drive, Baltimore, MD, 21224, USA.
Columbia College of Physicians and Surgeons, New York State Psychiatric Institute, New York, NY, USA.
Psychopharmacology (Berl). 2017 Feb;234(4):599-612. doi: 10.1007/s00213-016-4493-5. Epub 2016 Dec 5.
Although cocaine use has been linked to sexual HIV risk behavior for decades, the direct effects of cocaine on sexual desire and sexual decision-making are unexamined. Research suggests delay discounting (devaluation of future outcomes) and probability discounting (devaluation of uncertain outcomes) play roles in condom use decisions. This study examined the effect of cocaine administration on sexual desire, hypothetical condom use, and discounting tasks.
This double-blind, within-subjects study compared the effects of 0, 125, and 250 mg/70 kg oral cocaine HCl in 12 cocaine users. Measures included sexual desire and other subjective ratings, the Sexual Delay Discounting Task, the Sexual Probability Discounting Task, and monetary delay and probability discounting tasks.
Cocaine caused dose-related increases in sexual desire and prototypical stimulant abuse-liability ratings. Relative to placebo, cocaine did not significantly alter condom use likelihood when condoms were immediately available or when sex was associated with 100% certainty of sexually transmitted infection (STI). In contrast, cocaine dose-dependently strengthened the effect of delay (sexual delay discounting) and STI uncertainty (sexual probability discounting) in decreasing condom use likelihood. Cocaine caused no significant change in monetary delay and probability discounting.
This is the first study showing that cocaine administration increases sexual desire. Detrimental effects of cocaine on sexual risk were only observed when safer sex required delay, or STI risk was uncertain (representative of many real-world scenarios), suggesting a critical role of discounting processes. Lack of monetary effects highlights the importance of studying clinically relevant outcomes when examining drug effects on behavioral processes.
尽管数十年来可卡因的使用一直与感染艾滋病毒的性风险行为有关,但可卡因对性欲和性决策的直接影响尚未得到研究。研究表明,延迟折扣(对未来结果的贬值)和概率折扣(对不确定结果的贬值)在避孕套使用决策中起作用。本研究考察了可卡因给药对性欲、假设的避孕套使用以及折扣任务的影响。
这项双盲、受试者内研究比较了12名可卡因使用者服用0、125和250mg/70kg口服盐酸可卡因的效果。测量指标包括性欲和其他主观评分、性延迟折扣任务、性概率折扣任务以及金钱延迟和概率折扣任务。
可卡因导致性欲以及典型的兴奋剂滥用倾向评分呈剂量相关增加。相对于安慰剂,当避孕套立即可用时,或者当性行为与100%确定性的性传播感染(STI)相关时,可卡因并未显著改变使用避孕套的可能性。相比之下,可卡因剂量依赖性地增强了延迟(性延迟折扣)和性传播感染不确定性(性概率折扣)对降低使用避孕套可能性的影响。可卡因对金钱延迟和概率折扣没有显著影响。
这是第一项表明可卡因给药会增加性欲的研究。仅当安全性行为需要延迟,或者性传播感染风险不确定时(代表许多现实世界的情况),才观察到可卡因对性风险的有害影响,这表明折扣过程起着关键作用。缺乏金钱方面的影响凸显了在研究药物对行为过程的影响时,研究临床相关结果的重要性。